https://old.international-biopharma.com/pfizer-lays-out-gene-therapy-aspirations/ 2020-02-03T09:49:46+00:00 https://old.international-biopharma.com/preventive-alzheimers-trial-data-due-within-weeks-lilly-says/ 2020-02-03T09:48:06+00:00 https://old.international-biopharma.com/jj-launches-vaccine-efforts-as-coronavirus-spreads/ 2020-02-03T09:46:36+00:00 https://old.international-biopharma.com/big-pharma-backed-away-from-brain-drugs-is-a-return-in-sight/ 2020-02-03T09:40:51+00:00 https://old.international-biopharma.com/civica-advances-drug-supply-strategy-with-thermo-fisher-deal/ 2020-01-27T09:27:53+00:00 https://old.international-biopharma.com/lilly-seeking-out-more-dermira-like-deals-report/ 2020-01-27T09:26:38+00:00 https://old.international-biopharma.com/beigene-cancer-drug-data-sets-up-china-duel-with-merck/ 2020-01-27T09:24:03+00:00 https://old.international-biopharma.com/blue-cross-blue-shield-partners-with-civica-on-generic-drug-mission/ 2020-01-27T09:21:29+00:00 https://old.international-biopharma.com/fda-decision-nears-on-aimmunes-contested-peanut-allergy-drug/ 2020-01-27T09:20:00+00:00 https://old.international-biopharma.com/alexions-neuro-bet-rubius-trial-troubles-and-biotechs-gene-therapy-milestones/ 2020-01-20T09:31:56+00:00 https://old.international-biopharma.com/biomarin-sets-gene-therapy-sights-beyond-hemophilia/ 2020-01-20T09:30:18+00:00 https://old.international-biopharma.com/nationwide-childrens-a-gene-therapy-leader-launches-manufacturing-spinout/ 2020-01-20T09:29:12+00:00 https://old.international-biopharma.com/nektar-quickly-drops-opioid-drug-after-fda-panel-rejection/ 2020-01-20T09:27:45+00:00 https://old.international-biopharma.com/biontech-rescues-cancer-biotech-neon-in-bargain-buyout/ 2020-01-20T09:26:00+00:00 https://old.international-biopharma.com/illumina-scraps-1-2b-pacbio-takeover-amid-regulatory-pushback/ 2020-01-13T09:35:30+00:00 https://old.international-biopharma.com/pfizer-merck-kgaa-show-immunotherapys-survival-benefit-in-bladder-cancer/ 2020-01-13T09:34:16+00:00 https://old.international-biopharma.com/mercks-keytruda-falls-short-of-rivals-in-1-lung-cancer-type/ 2020-01-13T09:32:18+00:00 https://old.international-biopharma.com/us-cancer-death-rate-drops-by-most-on-record/ 2020-01-13T09:31:11+00:00 https://old.international-biopharma.com/amag-ceo-to-step-down-as-troubled-pharma-looks-to-sell-2-drugs/ 2020-01-13T09:29:57+00:00 https://old.international-biopharma.com/value-based-pricing-for-gene-therapy-maybe-not-ready-for-hemophilia/ 2019-12-16T09:48:26+00:00 https://old.international-biopharma.com/house-passes-drug-pricing-bill-that-pharma-warned-would-bring-nuclear-winter/ 2019-12-16T09:46:36+00:00 https://old.international-biopharma.com/hahn-confirmed-as-fda-head-to-lead-agency-as-drug-review-process-is-tested/ 2019-12-16T09:45:08+00:00 https://old.international-biopharma.com/in-stunning-twist-fda-approves-sareptas-duchenne-drug-it-rejected/ 2019-12-16T09:43:13+00:00 https://old.international-biopharma.com/uniqure-pfizer-updates-hint-at-gene-therapy-potential-in-hemophilia-b/ 2019-12-16T09:41:33+00:00 https://old.international-biopharma.com/after-fda-rejection-immunomedics-tries-again-with-breast-cancer-drug/ 2019-12-09T11:11:34+00:00 https://old.international-biopharma.com/new-approval-for-roches-tecentriq-heats-up-lung-cancer-battle-with-keytruda/ 2019-12-09T11:10:28+00:00 https://old.international-biopharma.com/novartis-highlights-4-drugs-of-future-in-laying-out-rd-vision/ 2019-12-09T11:08:51+00:00 https://old.international-biopharma.com/trial-setback-strikes-blow-to-sage-antidepressant-ambitions/ 2019-12-09T11:07:34+00:00 https://old.international-biopharma.com/the-clearest-picture-of-biogens-alzheimers-drug-is-still-fuzzy/ 2019-12-09T11:04:57+00:00 https://old.international-biopharma.com/i-believe-the-drug-works-biogen-cmo-defends-decision-to-submit-alzheimers-drug-to-fda/ 2019-11-29T10:51:50+00:00 https://old.international-biopharma.com/novartis-buys-medicines-co-in-9-7b-bet-on-cholesterol-drug/ 2019-11-29T10:50:12+00:00 https://old.international-biopharma.com/opioid-makers-subject-of-us-grand-jury-probe/ 2019-11-29T10:48:27+00:00 https://old.international-biopharma.com/global-bloods-sickle-cell-drug-wins-fda-approval-joining-novartis-adakveo/ 2019-11-29T10:46:48+00:00 https://old.international-biopharma.com/before-2019-closes-the-fda-has-3-key-approval-decisions-to-make/ 2019-11-29T10:44:39+00:00 https://old.international-biopharma.com/medicines-co-deal-caps-pharmas-reentry-into-field-it-once-abandoned/ 2019-11-29T10:41:12+00:00 https://old.international-biopharma.com/france-clears-way-for-wide-use-of-vertexs-orkambi/ 2019-11-25T10:34:38+00:00 https://old.international-biopharma.com/first-look-at-crispr-vertex-gene-editing-therapy-hints-at-treatment-potential/ 2019-11-25T10:33:06+00:00 https://old.international-biopharma.com/the-hemophilia-gene-therapy-race-faces-a-critical-year-in-2020/ 2019-11-25T10:31:26+00:00 https://old.international-biopharma.com/trump-fda-nominee-hahn-treads-familiar-ground-on-drugs-devices/ 2019-11-25T10:29:06+00:00 https://old.international-biopharma.com/takeda-sees-cell-gene-therapy-in-its-future-is-it-too-late/ 2019-11-25T10:27:44+00:00 https://old.international-biopharma.com/bankrupt-biopharmas-are-rare-2019-has-some-worried-thats-changing/ 2019-11-25T10:24:55+00:00 https://old.international-biopharma.com/chiron-behring-re-launches-rabies-vaccine-as-chirorab/ 2019-11-18T10:19:00+00:00 https://old.international-biopharma.com/novo-nordisk-education-foundation-unveils-first-year-report-of-impact-india/ 2019-11-18T10:02:40+00:00 https://old.international-biopharma.com/nec-vaximm-to-advance-personalized-neoantigen-cancer-vaccines/ 2019-11-18T09:53:31+00:00 https://old.international-biopharma.com/samsung-biologics-enhances-its-trusted-service/ 2019-11-18T09:47:45+00:00 https://old.international-biopharma.com/takeda-announces-12-new-molecular-entities/ 2019-11-18T09:39:51+00:00 https://old.international-biopharma.com/betting-on-the-bug-the-microbiomes-impact-on-drug-efficacy/ 2019-11-13T13:38:53+00:00 https://old.international-biopharma.com/turning-negatives-into-positives-how-dissenters-can-help-improve-rim-transformation-success/ 2019-11-13T13:35:38+00:00 https://old.international-biopharma.com/multi-modal-positron-emission-tomography-pet-advances-preclinical-pharmaceutical-research/ 2019-11-13T13:32:11+00:00 https://old.international-biopharma.com/biology-3-0-the-single-cell-revolution/ 2019-11-13T13:28:49+00:00 https://old.international-biopharma.com/crispr-advances-can-accelerate-biopharmaceutical-drug-discovery-and-development/ 2019-11-13T13:25:18+00:00 https://old.international-biopharma.com/becoming-a-champion-go-player/ 2019-11-13T13:21:23+00:00 https://old.international-biopharma.com/why-we-need-new-diagnostics-for-the-zika-virus/ 2019-11-13T13:16:12+00:00 https://old.international-biopharma.com/virus-like-particles-versatile-platforms/ 2019-11-13T13:12:32+00:00 https://old.international-biopharma.com/rapid-automated-at-line-antibody-titer-measurements-advance-biopharmaceutical-production/ 2019-11-13T13:08:01+00:00 https://old.international-biopharma.com/the-digital-content-revolution-of-the-pharmaceutical-industry/ 2019-11-13T11:57:26+00:00 https://old.international-biopharma.com/choice-matters-diminishing-options-as-a-result-of-industry-consolidation-place-new-pressure-on-customer-decision-making/ 2019-11-13T11:53:57+00:00 https://old.international-biopharma.com/idmp-back-on-track-and-bearing-down-with-new-urgency-what-next/ 2019-11-13T11:50:30+00:00 https://old.international-biopharma.com/china-approves-alzheimers-drug-inviting-fresh-debate-in-field-with-few-successes/ 2019-11-11T11:30:41+00:00 https://old.international-biopharma.com/regenxbio-hit-with-fda-clinical-hold-pushes-back-gene-therapy-timelines/ 2019-11-11T11:22:56+00:00 https://old.international-biopharma.com/as-fateful-fda-review-nears-amarin-makes-case-for-vascepa/ 2019-11-11T11:18:23+00:00 https://old.international-biopharma.com/biogen-broadens-biosimilar-bet-to-go-after-top-selling-eye-drugs/ 2019-11-11T11:15:35+00:00 https://old.international-biopharma.com/astrazenecas-china-ambitions-grow-with-new-rd-investments/ 2019-11-11T11:09:05+00:00 https://old.international-biopharma.com/trump-administration-sues-gilead-over-hiv-drug-patents/ 2019-11-11T11:03:45+00:00 https://old.international-biopharma.com/fda-approves-first-drug-for-anemia-tied-to-rare-blood-disorder/ 2019-11-11T10:59:07+00:00 https://old.international-biopharma.com/seattle-genetics-stock-hits-record-high-on-well-placed-breast-cancer-bet/ 2019-10-28T10:25:36+00:00 https://old.international-biopharma.com/brief-novartis-downplays-late-stage-asthma-drug-failures/ 2019-10-28T10:23:22+00:00 https://old.international-biopharma.com/questions-on-biogens-revival-of-a-failed-alzheimers-drug/ 2019-10-28T10:21:59+00:00 https://old.international-biopharma.com/in-major-surprise-biogen-will-ask-fda-to-approve-alzheimers-drug-aducanumab/ 2019-10-28T10:20:26+00:00 https://old.international-biopharma.com/novartis-zolgensma-starts-strong-as-about-100-infants-are-treated-with-gene-therapy/ 2019-10-28T10:19:15+00:00 https://old.international-biopharma.com/longtime-lilly-diabetes-chief-conterno-to-step-down/ 2019-10-28T10:17:17+00:00 https://old.international-biopharma.com/phillips-medisize-wins-contract-to-manufacture-first-electronic-enabled-combination-drug-delivery-product/ 2019-10-23T08:49:56+00:00 https://old.international-biopharma.com/merck-to-lay-off-500-us-based-employees/ 2019-10-21T12:46:32+00:00 https://old.international-biopharma.com/lilly-shuttering-uk-neuroscience-research-site/ 2019-10-21T12:44:05+00:00 https://old.international-biopharma.com/reata-surprises-with-positive-data-in-challenging-rare-disease/ 2019-10-21T12:41:19+00:00 https://old.international-biopharma.com/glenmark-spin-out-aims-to-challenge-amgen-others-in-cancer-bispecific-field/ 2019-10-21T12:38:44+00:00 https://old.international-biopharma.com/lilly-cancer-drug-pipeline-hit-by-trial-setback/ 2019-10-21T12:36:44+00:00 https://old.international-biopharma.com/product-characterization-reveal-your-molecule-earlier-faster-and-with-accuracy/ 2019-10-21T12:33:20+00:00 https://old.international-biopharma.com/revance-ceo-stepping-down-over-misjudgment/ 2019-10-21T12:28:26+00:00 https://old.international-biopharma.com/former-fda-chief-gottlieb-predicts-trump-pitched-pricing-model-easy-to-game/ 2019-10-11T14:22:52+00:00 https://old.international-biopharma.com/with-new-report-icer-puts-itself-at-center-of-drug-pricing-storm/ 2019-10-11T14:21:53+00:00 https://old.international-biopharma.com/milliporesigma-acquires-flodesign-sonics-for-acoustic-technology-for-cell-therapy/ 2019-10-11T14:20:57+00:00 https://old.international-biopharma.com/gene-therapy-biotechs-caught-in-manufacturing-crunch/ 2019-10-11T14:19:19+00:00 https://old.international-biopharma.com/treatment-of-pain-and-inflammation-with-tetra-bio-pharmas-caumz-kit/ 2019-10-11T14:17:08+00:00 https://old.international-biopharma.com/aridis-pharmaceuticals-appoints-infectious-disease-expert-paul-mendelman-md-as-interim-chief-medical-officer/ 2019-10-11T14:15:33+00:00 https://old.international-biopharma.com/over-80-iconic-landmarks-to-light-up-in-unity-across-the-globe-to-raise-awareness-for-stage-iv-metastatic-breast-cancer-in-october/ 2019-10-11T14:13:57+00:00 https://old.international-biopharma.com/brief-sarepta-in-shadow-of-fda-setback-marks-gene-therapy-progress/ 2019-10-07T09:02:51+00:00 https://old.international-biopharma.com/amicus-rare-disease-data-build-hope-for-approval/ 2019-10-07T08:41:38+00:00 https://old.international-biopharma.com/biogens-rd-head-is-out-following-string-of-clinical-setbacks/ 2019-10-07T08:40:13+00:00 https://old.international-biopharma.com/jj-paying-20m-to-settle-ohio-opioid-suits/ 2019-10-07T08:37:42+00:00 https://old.international-biopharma.com/sanofis-story-needs-to-be-better-told-new-ceo-says/ 2019-10-07T08:34:23+00:00 https://old.international-biopharma.com/how-to-relaunch-your-healthcare-website-in-the-new-era-of-search/ 2019-10-07T08:32:13+00:00 https://old.international-biopharma.com/novartis-microsoft-ink-5-year-ai-alliance/ 2019-10-07T08:27:46+00:00 https://old.international-biopharma.com/3-akcea-execs-including-ceo-leave-in-a-disconcerting-surprise/ 2019-09-27T14:25:16+00:00 https://old.international-biopharma.com/top-pelosi-aide-to-payers-help-us-defeat-big-pharma/ 2019-09-27T14:23:51+00:00 https://old.international-biopharma.com/is-the-future-of-diabetes-treatment-better-drugs-or-better-care/ 2019-09-27T14:22:16+00:00 https://old.international-biopharma.com/alders-migraine-drug-attracted-plenty-of-dealmakers-the-company-not-so-much/ 2019-09-27T14:20:29+00:00 https://old.international-biopharma.com/fda-warning-slowed-immunotherapy-use-in-bladder-cancer/ 2019-09-27T14:16:47+00:00 https://old.international-biopharma.com/first-of-its-kind-trial-in-als-spurs-hope-for-brutal-disease/ 2019-09-27T14:13:42+00:00 https://old.international-biopharma.com/cphi-pharmaceutical-machinery-report-critical-time-to-invest-in-machinery-with-changing-drugs-pipeline/ 2019-09-26T10:39:41+00:00 https://old.international-biopharma.com/ebola-vaccine-from-merck-takes-step-toward-us-approval/ 2019-09-19T14:03:54+00:00 https://old.international-biopharma.com/vertex-hits-a-biomarker-bump-on-road-to-new-drug/ 2019-09-19T14:02:52+00:00 https://old.international-biopharma.com/5-questions-esmo-cancer-drug-data-might-answer/ 2019-09-19T14:01:15+00:00 https://old.international-biopharma.com/opioid-giant-purdue-files-for-bankruptcy-to-pay-for-sweeping-settlement/ 2019-09-19T13:59:21+00:00 https://old.international-biopharma.com/acceleron-dealt-pipeline-setback/ 2019-09-19T13:57:18+00:00 https://old.international-biopharma.com/lundbeck-buys-into-migraine-acquiring-alder-for-2b/ 2019-09-19T12:55:11+00:00 https://old.international-biopharma.com/trial-win-could-drive-acadias-nuplazid-to-new-use/ 2019-09-12T12:56:48+00:00 https://old.international-biopharma.com/survey-suggests-ionis-is-losing-battle-against-pfizer-and-alnylam/ 2019-09-12T12:52:56+00:00 https://old.international-biopharma.com/after-scandal-novartis-pledges-faster-action-on-data-integrity/ 2019-09-12T12:48:57+00:00 https://old.international-biopharma.com/drug-companies-pay-for-exclusive-access-to-uk-genetic-data/ 2019-09-12T12:45:48+00:00 https://old.international-biopharma.com/the-evolution-of-the-patient-experience/ 2019-09-12T12:42:49+00:00 https://old.international-biopharma.com/public-trust-in-drugmakers-is-at-an-all-time-low-can-biopharma-recover/ 2019-09-12T12:37:59+00:00 https://old.international-biopharma.com/media-information-2020/ 2019-09-10T15:54:03+00:00 https://old.international-biopharma.com/vertex-to-buy-biotech-for-950m-for-type-1-diabetes-cure/ 2019-09-06T13:50:18+00:00 https://old.international-biopharma.com/medicines-co-s-cholesterol-drug-good-to-take-on-pcsk9-rivals/ 2019-09-06T13:44:56+00:00 https://old.international-biopharma.com/uniqure-stays-a-step-ahead-in-hemophilia-b/ 2019-09-06T13:39:49+00:00 https://old.international-biopharma.com/prevention-studies-next-big-test-for-alzheimers-research/ 2019-09-06T13:26:57+00:00 https://old.international-biopharma.com/novartis-vies-for-multiple-sclerosis-dominance/ 2019-09-06T13:21:20+00:00 https://old.international-biopharma.com/amgen-puts-its-kras-hopes-on-navy-seals-team-of-drug-hunters/ 2019-09-06T13:11:25+00:00 https://old.international-biopharma.com/new-drug-shows-encouraging-survival-in-pancreatic-cancer/ 2019-09-02T08:41:52+00:00 https://old.international-biopharma.com/treating-resistant-prostate-cancer-by-depriving-a-key-hormone-of-its-co-pilot/ 2019-09-02T08:41:06+00:00 https://old.international-biopharma.com/could-gene-therapy-be-the-solution-to-obesity-and-diabetes/ 2019-09-02T08:40:25+00:00 https://old.international-biopharma.com/a-new-drug-could-revolutionize-the-treatment-of-neurological-disorders/ 2019-09-02T08:39:35+00:00 https://old.international-biopharma.com/gene-editing-companies-oppose-altering-of-embryos/ 2019-09-02T08:38:52+00:00 https://old.international-biopharma.com/interactions-discovered-in-cells-insulating-nerve-pathways/ 2019-09-02T08:38:12+00:00 https://old.international-biopharma.com/drug-accelerates-blood-systems-recovery-after-chemotherapy-radiation/ 2019-08-27T10:29:18+00:00 https://old.international-biopharma.com/sarepta-now-needs-flawless-progress-for-gene-therapy/ 2019-08-27T10:23:20+00:00 https://old.international-biopharma.com/pfizer-injects-500m-more-into-gene-therapy-manufacturing/ 2019-08-27T10:20:27+00:00 https://old.international-biopharma.com/as-supply-shortages-persist-adma-relaunches-immune-globulin-dru/ 2019-08-27T10:16:16+00:00 https://old.international-biopharma.com/tumor-cell-metabolism-diagnostic-could-predict-nsclc-treatment-responses-study/ 2019-08-27T10:09:50+00:00 https://old.international-biopharma.com/crispr-slows-the-growth-of-triple-negative-breast-cancer-in-mice/ 2019-08-27T09:56:17+00:00 https://old.international-biopharma.com/ultragenyx-snags-option-on-antisense-startup-genetx/ 2019-08-19T10:17:28+00:00 https://old.international-biopharma.com/treating-glioblastoma-with-a-ziopharm-drug-and-il-12-gene-therapy/ 2019-08-19T10:14:16+00:00 https://old.international-biopharma.com/hospitalized-gene-therapy-patient-triggers-sarepta-sell-off/ 2019-08-19T10:00:45+00:00 https://old.international-biopharma.com/sickle-cell-setback-triggers-share-slide-at-glycomimetics/ 2019-08-19T09:58:51+00:00 https://old.international-biopharma.com/how-nematode-worms-could-inspire-safer-opioid-use/ 2019-08-19T09:50:25+00:00 https://old.international-biopharma.com/agilent-unveils-combination-real-time-cell-imager-and-analyzer-following-acea-acquisition/ 2019-08-19T09:48:49+00:00 https://old.international-biopharma.com/glaxosmithkline-taps-taras-beating-heart-on-a-chip-to-simulate-cardiac-drug-responses/ 2019-08-12T09:49:19+00:00 https://old.international-biopharma.com/bayer-buys-rest-of-bluerock-broadening-cell-therapy-bet/ 2019-08-12T09:11:57+00:00 https://old.international-biopharma.com/novartis-ceo-on-defense-as-data-scandal-clouds-gene-therapy-approval/ 2019-08-12T09:08:15+00:00 https://old.international-biopharma.com/how-duocar-t-cells-could-clear-hiv-and-prevent-resurgence-of-virus-reservoirs/ 2019-08-12T09:01:56+00:00 https://old.international-biopharma.com/personalized-blood-test-pinpoints-early-breast-cancer-in-preliminary-study/ 2019-08-12T08:59:26+00:00 https://old.international-biopharma.com/a-map-of-liver-cells-provides-insights-that-could-boost-search-for-nash-drugs/ 2019-08-12T08:49:17+00:00 https://old.international-biopharma.com/japanese-scientists-plan-to-create-human-mouse-hybrids/ 2019-08-05T09:38:16+00:00 https://old.international-biopharma.com/freezing-your-t-cells-today-for-potential-car-t-therapies-tomorrow/ 2019-08-05T09:18:59+00:00 https://old.international-biopharma.com/could-stem-cell-transplants-make-bms-checkpoint-inhibitors-work-in-resistant-lymphoma/ 2019-08-05T09:17:14+00:00 https://old.international-biopharma.com/biomarin-drops-lower-dose-of-its-hemophilia-gene-therapy-as-it-eyes-submissions-by-year-end/ 2019-08-05T09:09:38+00:00 https://old.international-biopharma.com/amicus-gives-early-look-at-batten-disease-gene-therapy/ 2019-08-05T09:04:40+00:00 https://old.international-biopharma.com/closing-the-door-breaking-new-ground-related-to-a-potential-anticancer-drug-target/ 2019-08-05T09:01:40+00:00 https://old.international-biopharma.com/driving-sci-tech-growth-in-the-uk-regions/ 2019-07-31T10:26:51+00:00 https://old.international-biopharma.com/betting-on-the-bug-how-the-microbiome-can-improve-reproducibility-and-translatability/ 2019-07-31T10:24:12+00:00 https://old.international-biopharma.com/key-challenges-and-potential-solutions-for-optimising-downstream-bioprocessing-production/ 2019-07-31T10:21:35+00:00 https://old.international-biopharma.com/gene-therapy-bubble-boy-and-beyond/ 2019-07-31T10:18:36+00:00 https://old.international-biopharma.com/changing-state-of-clinical-trials-in-the-digital-era/ 2019-07-31T10:15:57+00:00 https://old.international-biopharma.com/a-statistical-approach-to-improve-compound-screening-in-cell-culture-media/ 2019-07-31T10:12:37+00:00 https://old.international-biopharma.com/importance-of-the-quality-system-production-quality-control-quality-assurance/ 2019-07-31T10:07:24+00:00 https://old.international-biopharma.com/rapid-host-cell-protein-hcp-detection-with-advanced-trapped-ion-mobility-spectrometry-tims-technology/ 2019-07-31T10:04:22+00:00 https://old.international-biopharma.com/enhancing-cell-line-development-and-streamlining-processes-through-single-cell-technology/ 2019-07-31T10:01:03+00:00 https://old.international-biopharma.com/how-to-gain-the-greatest-blockchain-value-for-your-business/ 2019-07-31T09:57:01+00:00 https://old.international-biopharma.com/connected-labelling-the-holy-grail-that-continues-to-elude-life-sciences/ 2019-07-31T09:53:46+00:00 https://old.international-biopharma.com/the-fda-is-shifting-focus-to-both-ends-of-the-product-development-spectrum/ 2019-07-31T09:48:30+00:00 https://old.international-biopharma.com/innovations-in-cold-chain-technology/ 2019-07-31T09:43:51+00:00 https://old.international-biopharma.com/editas-allergan-kick-off-long-awaited-in-vivo-crispr-trial/ 2019-07-29T09:10:14+00:00 https://old.international-biopharma.com/artificial-protein-programs-cells-to-fight-disease/ 2019-07-29T09:01:16+00:00 https://old.international-biopharma.com/vertex-ceo-to-step-down-setting-stage-for-first-female-chief-among-top-biotechs/ 2019-07-29T08:54:34+00:00 https://old.international-biopharma.com/ultragenyx-close-to-learning-whether-gene-therapy-gamble-will-pay-off/ 2019-07-29T08:52:50+00:00 https://old.international-biopharma.com/hiv-vaccine-nears-clinical-trial-following-new-findings/ 2019-07-29T08:47:58+00:00 https://old.international-biopharma.com/abbvie-bets-on-early-immuno-oncology-asset/ 2019-07-16T14:09:54+00:00 https://old.international-biopharma.com/sosei-heptares-pens-1b-biobucks-gpcr-pact-with-genentech/ 2019-07-16T14:05:05+00:00 https://old.international-biopharma.com/trefoil-therapeutics-banks-28m-to-create-first-drug-for-genetic-eye-disorder/ 2019-07-16T14:02:33+00:00 https://old.international-biopharma.com/revolution-medicines-snags-100m-to-attack-ras-mutated-cancers/ 2019-07-15T15:08:49+00:00 https://old.international-biopharma.com/could-the-hunger-hormone-boost-memory/ 2019-07-15T15:05:53+00:00 https://old.international-biopharma.com/gilead-forges-closer-ties-with-galapagos-in-5-1b-deal/ 2019-07-15T14:59:03+00:00 https://old.international-biopharma.com/boehringer-buys-up-cancer-vaccine-player-eyes-oncology-combo-strategy/ 2019-07-15T14:51:33+00:00 https://old.international-biopharma.com/crispr-pioneer-zhang-targets-brain-diseases-with-new-rna-editing-system/ 2019-07-12T13:49:32+00:00 https://old.international-biopharma.com/boosting-car-t-to-treat-solid-tumors-with-a-vaccine/ 2019-07-12T13:47:33+00:00 https://old.international-biopharma.com/pathogen-engineered-to-self-destruct-underlies-cancer-vaccine-platform/ 2019-07-12T13:44:55+00:00 https://old.international-biopharma.com/natural-antioxidant-helps-improve-immune-based-therapies-by-modulating-t-cells/ 2019-07-12T13:41:47+00:00 https://old.international-biopharma.com/biomarin-confirms-timeline-for-hemophilia-gene-therapy-putting-pressure-on-rivals/ 2019-07-12T13:39:21+00:00 https://old.international-biopharma.com/brief-hunting-better-biomarkers-jj-taps-celsius-to-unpack-role-played-by-single-cells/ 2019-07-12T13:35:43+00:00 https://old.international-biopharma.com/semma-plans-trials-of-stem-cell-derived-islets-in-diabetes-scientists-grow-hair-from-stem-cells/ 2019-07-08T08:55:20+00:00 https://old.international-biopharma.com/sangamo-backs-up-early-success-for-hemophilia-gene-therapy/ 2019-07-08T08:50:37+00:00 https://old.international-biopharma.com/pressing-the-pause-button-on-car-t-cells-with-bristol-myers-leukemia-drug/ 2019-07-08T08:46:41+00:00 https://old.international-biopharma.com/subtle-chemical-shift-reverses-prediabetes-in-merck-partnered-mouse-trial/ 2019-07-08T08:44:45+00:00 https://old.international-biopharma.com/using-crispr-to-eliminate-hiv/ 2019-07-08T08:41:43+00:00 https://old.international-biopharma.com/bayer-backs-cell-therapy-startup-with-215m-in-funding/ 2019-07-08T08:36:48+00:00 https://old.international-biopharma.com/axovant-signs-yposkesi-as-manufacturing-partner/ 2019-07-01T09:23:16+00:00 https://old.international-biopharma.com/treating-pancreatic-cancer-by-starving-tumor-cells/ 2019-07-01T09:11:57+00:00 https://old.international-biopharma.com/new-evidence-of-a-link-between-parkinsons-disease-and-the-gut-could-inspire-treatments/ 2019-07-01T09:07:04+00:00 https://old.international-biopharma.com/pfizer-muscular-dystrophy-gene-therapy-stumbles-on-safety/ 2019-07-01T09:01:02+00:00 https://old.international-biopharma.com/how-gastric-stem-cells-fight-bacteria/ 2019-07-01T08:57:09+00:00 https://old.international-biopharma.com/artificial-dna-can-control-release-of-active-ingredients-from-drugs/ 2019-07-01T08:56:21+00:00 https://old.international-biopharma.com/biomarin-readies-hemophilia-gene-therapy-for-fda-submission/ 2019-06-24T09:32:16+00:00 https://old.international-biopharma.com/bluebird-sets-1-8m-price-tag-for-blood-disease-gene-therapy/ 2019-06-24T09:26:13+00:00 https://old.international-biopharma.com/sanofi-to-ax-466-jobs-step-up-focus-on-cancer-gene-therapy-rd/ 2019-06-24T09:22:31+00:00 https://old.international-biopharma.com/how-a-long-known-biomarker-backs-biontechs-antibody-for-pancreatic-cancer/ 2019-06-24T09:19:24+00:00 https://old.international-biopharma.com/bluebird-delays-gene-therapy-launch-to-2020-citing-manufacturing-tweaks/ 2019-06-24T09:16:01+00:00 https://old.international-biopharma.com/making-it-personal-how-genetic-technologies-are-changing-the-face-of-medicine/ 2019-06-24T09:04:40+00:00 https://old.international-biopharma.com/early-cancer-drug-data-give-amgen-hope-it-has-cracked-kras-code/ 2019-06-14T12:36:36+00:00 https://old.international-biopharma.com/gilead-abcellera-ink-infectious-disease-antibody-discovery-pact/ 2019-06-14T12:33:12+00:00